Display options
Share it on

Postepy Dermatol Alergol. 2016 Feb;33(1):63-7. doi: 10.5114/pdia.2015.48052. Epub 2016 Feb 29.

Occurrence of sleep-related breathing disorders in patients with chronic urticaria at its asymptomatic or oligosymptomatic stages.

Postepy dermatologii i alergologii

Jolanta Perkowska, Jerzy Kruszewski, Piotr Gutkowski, Andrzej Chciałowski, Krzysztof Kłos

Affiliations

  1. Department of Infectious Diseases and Allergology, Military Institute of Medicine, Warsaw, Poland.
  2. Non-invasive Cardiology and Telemedicine Ward, Military Institute of Medicine, Warsaw, Poland.
  3. Military Institute of Medicine, Warsaw, Poland.

PMID: 26985182 PMCID: PMC4793057 DOI: 10.5114/pdia.2015.48052

Abstract

INTRODUCTION: Chronic urticaria (CU), in view of its manifestations (pruritus, wheals), chronic and recurrent nature is very bothersome for patients and significantly influences their quality of life.

AIM: To assess the importance of sleep problems and sleep-related breathing disorders (SRBDs) declared by CU patients, for their quality of life.

MATERIAL AND METHODS: Twenty-eight patients with CU at an asymptomatic stage or with minimal symptoms and signs were qualified for the study. In these patients, assessment of urticaria severity, QoL and SRBDs incidence was carried out.

RESULTS: In a questionnaire study (CU-Q2oL), about 54% of the patients with CU complained of sleeping problems, about 80% reported significant fatigue and lack of concentration in the daytime. Respiratory polygraphy, an objective measure of sleep-related breathing disorders (SRBDs) demonstrated their higher incidence in patients with CU than in the general population, but these disorders were mild and had no influence on the reduced quality of life of the study patients, compared with a group of patients without SRBDs.

CONCLUSIONS: The occurrence of SRBDs was found in 25% of patients with CU at asymptomatic or oligosymptomatic stages. The SRBDs in those patients were mild, required no treatment and their occurrence did not cause any significant reduction in their quality of life.

Keywords: CU-Q2oL; chronic urticaria; quality of life; respiratory polygraphy; sleep-related breathing disorders

References

  1. Clin Exp Dermatol. 1994 May;19(3):210-6 - PubMed
  2. Sleep Med Rev. 2011 Feb;15(1):65-74 - PubMed
  3. Pneumonol Alergol Pol. 2007;75 Suppl 1:15-9 - PubMed
  4. Med Care. 1992 Jun;30(6):473-83 - PubMed
  5. Med Pr. 2008;59(4):279-85 - PubMed
  6. J Drugs Dermatol. 2010 May;9(5):503-12 - PubMed
  7. Eur J Neurosci. 2004 Aug;20(3):803-10 - PubMed
  8. Br J Dermatol. 1999 Apr;140(4):667-71 - PubMed
  9. J Dtsch Dermatol Ges. 2013 Oct;11(10):971-7; quiz 978 - PubMed
  10. Allergy. 2005 Aug;60(8):1073-8 - PubMed
  11. Postepy Dermatol Alergol. 2013 Jun;30(3):146-51 - PubMed
  12. Allergy. 2009 Oct;64(10):1417-26 - PubMed
  13. J Am Acad Dermatol. 1997 Jul;37(1):41-50 - PubMed
  14. J Invest Dermatol. 1996 Nov;107(5):707-13 - PubMed
  15. J Dermatol Sci. 2011 Apr;62(1):36-41 - PubMed
  16. Pneumonol Alergol Pol. 2013;81(3):221-58 - PubMed

Publication Types